https://m6achemical.com/detect....ion-regarding-sars-c
Methods We compared post-CR (July 2014-June 2015) with baseline (July 2013-June 2014), evaluating usage of cefepime, cefazolin, ceftriaxone, ampicillin derivatives, fluoroquinolones, piperacillin/tazobactam, ertapenem, and meropenem; brand-new Clostridium difficile illness; and duration of stay (LOS) after the good culture, 30-day readmission, and in-hospital all-cause mortality. Outcomes Mean times of therapy (DOTital mortality. © The Author(s) 2020. Published by Oxford University Press on behalf of I